Showing results (241-250 of 301) with videos related to
Sort By:
Pageof 31
Influenza and Other Respiratory Viruses|March 21, 2019
Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the PhilippinesFumihiko Ueno, Raita Tamaki, Mayuko Saito, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy]Yutaka Kimura, Yoichi Makari, Johta Mikami, et al.Cancer Medicine|June 13, 2020
Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancerMiyabi Miura, Eishiro Mizukoshi, Tomomi Hashiba, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Three Cases of Bleeding from Advanced Gastric Cancer Treated by Transcatheter Arterial Embolization(TAE)and Continued Chemotherapy]Yoko Hiraki, Yutaka Kimura, Yoichi Makari, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[A trial of TS-1 administration on the basis of the pharmacokinetic study for an advanced gastric cancer patient with impaired renal function]Kazuyoshi Yamamoto, Hiroshi Imamura, Hiroshi Furukawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2008
[A case of advanced gastric cancer with obstructive jaundice due to liver metastases successfully treated with chemotherapy]Yasuhiro Miyazaki, Hiroshi Imamura, Hiroshi Furukawa, et al.Anticancer Research|July 3, 2017
Clinical Study on the Medical Value of Combination Therapy Involving Adoptive Immunotherapy and Chemotherapy for Stage IV Colorectal Cancer (COMVI Study)Yoichiro Yoshida, Masayasu Naito, Teppei Yamada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2008
[A case of S-1 resistant multiple lung metastases after curative total gastrectomy for gastric cancer successfully treated by S-1 combined with CPT-11 as the third-line chemotherapy]Hiroshi Imamura, Hiroshi Furukawa, Tomono Kishimoto, et al.Health Security|April 28, 2026
Systematic Framework for Interpreting Laboratory-Confirmed Infectious Disease Surveillance Data: A Pragmatic Scenario-Based ApproachYuzo Arima, Kazuhiko Kanou, Hirofumi Kato, et al.Clinical and Experimental Medicine|October 10, 2015
Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancerTomoharu Miyashita, Kenji Miki, Takashi Kamigaki, et al.Pageof 31